AQST
Aquestive Therapeutics, Inc.$3.75-0.16 (-4.09%)Prev Close$3.91·MCap$491.4M·P/E—·Vol1.52M·Yield—
▲
Buys (12M)
1
$99.3K
▼
Sells (12M)
17
$2.43M
◆
Net Activity
Net Seller
$2.33M
●
Active Insiders
10
last 12 mo
Over the past 12 months, insider activity at Aquestive Therapeutics, Inc. (AQST) has been dominated by selling, with 1 insider purchase totaling $99.3K and 17 insider sales totaling $2.43M. The most recent insider transaction was by Davis Matthew W. (officer: Chief Development Officer), who sold $25.5K worth of shares on Nov 16, 2026. Aquestive Therapeutics, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $491.4M.
AQST Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Davis Matthew W. | officer: Chief Development Officer | Sell | 7,197 | $3.55 | $25.5K | 87,500 |
| Nov 12, 2026 | Daly Richard J | director | Buy | 28,025 | $3.54 | $99.3K | 28,025 |
| Oct 16, 2026 | Barber Daniel | director, officer: President and CEO | Sell | 25,000 | $4.22 | $105.6K | 627,317 |
| Sep 16, 2026 | Barber Daniel | director, officer: President and CEO | Sell | 25,000 | $4.82 | $120.5K | 652,317 |
| Sep 11, 2026 | Korczynski Sherry | officer: Chief Commercial Officer | Sell | 8,750 | $5.22 | $45.7K | 235,689 |
| Aug 18, 2026 | Barber Daniel | director, officer: President and CEO | Sell | 25,000 | $4.29 | $107.2K | 585,574 |
| Jul 17, 2026 | Barber Daniel | officer: President and CEO | Sell | 25,000 | $4.01 | $100.2K | 630,943 |
| Jun 24, 2026 | Krop Julie | director | Sell | 25,000 | $5.02 | $125.4K | 0Exit |
| Jun 16, 2026 | Barber Daniel | officer: President and CEO | Sell | 25,000 | $4.16 | $104.0K | 635,574 |
| May 18, 2026 | Barber Daniel | officer: President and CEO | Sell | 8,257 | $4.29 | $35.4K | 660,574 |
| Mar 11, 2026 | Barber Daniel | officer: President and CEO | Sell | 180,677 | $4.17 | $754.0K | 1,004,753 |
| Mar 11, 2026 | Boyd Peter E. | officer: Chief People Officer | Sell | 29,814 | $4.17 | $124.4K | 338,509 |
| Mar 11, 2026 | BRAENDER LORI J | officer: Chief Legal Officer | Sell | 40,102 | $4.17 | $167.3K | 442,879 |
| Mar 11, 2026 | Cioffi Melina | officer: SVP, Regulatory Affairs | Sell | 25,311 | $4.17 | $105.6K | 274,867 |
| Mar 11, 2026 | Jung Cassie | officer: Chief Operating Officer | Sell | 45,791 | $4.17 | $191.1K | 274,980 |
| Mar 11, 2026 | Korczynski Sherry | officer: Chief Commercial Officer | Sell | 15,741 | $4.17 | $65.7K | 241,117 |
| Mar 11, 2026 | TOTH A ERNEST JR | officer: Chief Financial Officer | Sell | 58,254 | $4.17 | $243.1K | 376,112 |
| Dec 2, 2025 | Cioffi Melina | SVP, Regulatory Affairs | Sell | 2,083 | $5.93 | $12.4K | 0 |
| Oct 15, 2025 | Boyd Peter E. | See Remarks | Sell | 10,000 | $7.00 | $70.0K | 0 |
| Oct 15, 2025 | Jung Cassie | Chief Operating Officer | Sell | 67,575 | $7.01 | $473.7K | 0 |
| Oct 15, 2025 | Kraus Carl N | Chief Medical Officer | Sell | 20,272 | $7.00 | $141.9K | 0 |
| Sep 26, 2025 | Barber Daniel | President and CEO | Sell | 91,343 | $6.03 | $551.2K | 0 |
| Sep 26, 2025 | Boyd Peter E. | See Remarks | Sell | 10,000 | $6.30 | $63.0K | 0 |
| Sep 19, 2025 | Barber Daniel | President and CEO | Sell | 400 | $6.00 | $2.4K | 0 |
| Sep 5, 2025 | Boyd Peter E. | See Remarks | Sell | 15,000 | $5.30 | $79.5K | 0 |
| Sep 4, 2025 | Jung Cassie | Chief Operating Officer | Sell | 62,180 | $5.00 | $310.9K | 0 |
| Aug 9, 2025 | Kraus Carl N | Chief Medical Officer | Sell | 10,819 | $3.90 | $42.2K | 0 |
| Jun 9, 2025 | Korczynski Sherry | SVP Sales and Marketing | Sell | 2,714 | $3.54 | $9.6K | 0 |
| Mar 7, 2025 | Barber Daniel | President and CEO | Sell | 83,305 | $2.65 | $220.8K | 0 |
| Mar 7, 2025 | Boyd Peter E. | See Remark | Sell | 14,305 | $2.65 | $37.9K | 0 |
| Mar 7, 2025 | BRAENDER LORI J | Chief Legal Officer | Sell | 20,250 | $2.65 | $53.7K | 0 |
| Mar 7, 2025 | Jung Cassie | Chief Operating Officer | Sell | 17,540 | $2.64 | $46.2K | 0 |
| Mar 7, 2025 | Korczynski Sherry | SVP Sales and Marketing | Sell | 5,428 | $2.65 | $14.4K | 0 |
| Mar 7, 2025 | Kraus Carl N | Chief Medical Officer | Sell | 8,115 | $2.65 | $21.5K | 0 |
| Mar 7, 2025 | TOTH A ERNEST JR | Chief Financial Officer | Sell | 18,929 | $2.65 | $50.2K | 0 |
| Mar 7, 2025 | Wargacki Stephen | Chief Science Officer | Sell | 32,862 | $2.63 | $86.6K | 0 |
| Nov 26, 2024 | Jung Cassie | Chief Operating Officer | Sell | 44 | $4.87 | $214.06 | 0 |
| Aug 9, 2024 | Kraus Carl N | Chief Medical Officer | Sell | 10,819 | $3.43 | $37.1K | 0 |
| Mar 15, 2024 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sell | 50,000 | $6.00 | $300.0K | 0 |
| Mar 9, 2024 | Barber Daniel | President and CEO | Sell | 37,938 | $4.88 | $185.1K | 0 |
| Mar 9, 2024 | Boyd Peter E. | See Remark | Sell | 8,370 | $4.88 | $40.8K | 0 |
| Mar 9, 2024 | BRAENDER LORI J | SVP, General Counsel | Sell | 10,530 | $4.88 | $51.4K | 0 |
| Mar 9, 2024 | Jung Cassie | SVP, Operations | Sell | 9,432 | $4.88 | $46.0K | 0 |
| Mar 9, 2024 | TOTH A ERNEST JR | SVP, Chief Financial Officer | Sell | 11,705 | $4.88 | $57.1K | 0 |
| Mar 9, 2024 | Wargacki Stephen | SVP, Research & Development | Sell | 12,956 | $4.88 | $63.2K | 0 |
| Mar 8, 2024 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sell | 30,895 | $5.13 | $158.5K | 0 |
| Mar 10, 2023 | Wargacki Stephen | SVP, Research & Development | Sell | 1,981 | $0.79 | $1.6K | 0 |
| Jun 14, 2022 | Boyd Peter E. | SVP-Bus. Process & Info. Tech. | Buy | 5,000 | $0.81 | $4.0K | 0 |
| Jun 8, 2022 | Barber Daniel | Chief Executive Officer | Buy | 91,743 | $0.96 | $88.1K | 0 |
| Jun 8, 2022 | Boyd Peter E. | SVP-Bus. Process & Info. Tech. | Buy | 2,293 | $0.96 | $2.2K | 0 |
Showing 1–50 of 52
1 / 2
AQST Insider Buying Activity
The following table shows recent insider purchases of Aquestive Therapeutics, Inc. (AQST) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Daly Richard J | director | Buy | 28,025 | $3.54 | $99.3K | 28,025 |
| Jun 14, 2022 | Boyd Peter E. | SVP-Bus. Process & Info. Tech. | Buy | 5,000 | $0.81 | $4.0K | 0 |
| Jun 8, 2022 | Barber Daniel | Chief Executive Officer | Buy | 91,743 | $0.96 | $88.1K | 0 |
| Jun 8, 2022 | Boyd Peter E. | SVP-Bus. Process & Info. Tech. | Buy | 2,293 | $0.96 | $2.2K | 0 |
AQST Insider Selling Activity
The following table shows recent insider sales of Aquestive Therapeutics, Inc. (AQST) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Davis Matthew W. | officer: Chief Development Officer | Sell | 7,197 | $3.55 | $25.5K | 87,500 |
| Oct 16, 2026 | Barber Daniel | director, officer: President and CEO | Sell | 25,000 | $4.22 | $105.6K | 627,317 |
| Sep 16, 2026 | Barber Daniel | director, officer: President and CEO | Sell | 25,000 | $4.82 | $120.5K | 652,317 |
| Sep 11, 2026 | Korczynski Sherry | officer: Chief Commercial Officer | Sell | 8,750 | $5.22 | $45.7K | 235,689 |
| Aug 18, 2026 | Barber Daniel | director, officer: President and CEO | Sell | 25,000 | $4.29 | $107.2K | 585,574 |
| Jul 17, 2026 | Barber Daniel | officer: President and CEO | Sell | 25,000 | $4.01 | $100.2K | 630,943 |
| Jun 24, 2026 | Krop Julie | director | Sell | 25,000 | $5.02 | $125.4K | 0Exit |
| Jun 16, 2026 | Barber Daniel | officer: President and CEO | Sell | 25,000 | $4.16 | $104.0K | 635,574 |
| May 18, 2026 | Barber Daniel | officer: President and CEO | Sell | 8,257 | $4.29 | $35.4K | 660,574 |
| Mar 11, 2026 | Barber Daniel | officer: President and CEO | Sell | 180,677 | $4.17 | $754.0K | 1,004,753 |
| Mar 11, 2026 | Boyd Peter E. | officer: Chief People Officer | Sell | 29,814 | $4.17 | $124.4K | 338,509 |
| Mar 11, 2026 | BRAENDER LORI J | officer: Chief Legal Officer | Sell | 40,102 | $4.17 | $167.3K | 442,879 |
| Mar 11, 2026 | Cioffi Melina | officer: SVP, Regulatory Affairs | Sell | 25,311 | $4.17 | $105.6K | 274,867 |
| Mar 11, 2026 | Jung Cassie | officer: Chief Operating Officer | Sell | 45,791 | $4.17 | $191.1K | 274,980 |
| Mar 11, 2026 | Korczynski Sherry | officer: Chief Commercial Officer | Sell | 15,741 | $4.17 | $65.7K | 241,117 |
| Mar 11, 2026 | TOTH A ERNEST JR | officer: Chief Financial Officer | Sell | 58,254 | $4.17 | $243.1K | 376,112 |
| Dec 2, 2025 | Cioffi Melina | SVP, Regulatory Affairs | Sell | 2,083 | $5.93 | $12.4K | 0 |
| Oct 15, 2025 | Boyd Peter E. | See Remarks | Sell | 10,000 | $7.00 | $70.0K | 0 |
| Oct 15, 2025 | Jung Cassie | Chief Operating Officer | Sell | 67,575 | $7.01 | $473.7K | 0 |
| Oct 15, 2025 | Kraus Carl N | Chief Medical Officer | Sell | 20,272 | $7.00 | $141.9K | 0 |
| Sep 26, 2025 | Barber Daniel | President and CEO | Sell | 91,343 | $6.03 | $551.2K | 0 |
| Sep 26, 2025 | Boyd Peter E. | See Remarks | Sell | 10,000 | $6.30 | $63.0K | 0 |
| Sep 19, 2025 | Barber Daniel | President and CEO | Sell | 400 | $6.00 | $2.4K | 0 |
| Sep 5, 2025 | Boyd Peter E. | See Remarks | Sell | 15,000 | $5.30 | $79.5K | 0 |
| Sep 4, 2025 | Jung Cassie | Chief Operating Officer | Sell | 62,180 | $5.00 | $310.9K | 0 |
| Aug 9, 2025 | Kraus Carl N | Chief Medical Officer | Sell | 10,819 | $3.90 | $42.2K | 0 |
| Jun 9, 2025 | Korczynski Sherry | SVP Sales and Marketing | Sell | 2,714 | $3.54 | $9.6K | 0 |
| Mar 7, 2025 | Barber Daniel | President and CEO | Sell | 83,305 | $2.65 | $220.8K | 0 |
| Mar 7, 2025 | Boyd Peter E. | See Remark | Sell | 14,305 | $2.65 | $37.9K | 0 |
| Mar 7, 2025 | BRAENDER LORI J | Chief Legal Officer | Sell | 20,250 | $2.65 | $53.7K | 0 |
| Mar 7, 2025 | Jung Cassie | Chief Operating Officer | Sell | 17,540 | $2.64 | $46.2K | 0 |
| Mar 7, 2025 | Korczynski Sherry | SVP Sales and Marketing | Sell | 5,428 | $2.65 | $14.4K | 0 |
| Mar 7, 2025 | Kraus Carl N | Chief Medical Officer | Sell | 8,115 | $2.65 | $21.5K | 0 |
| Mar 7, 2025 | TOTH A ERNEST JR | Chief Financial Officer | Sell | 18,929 | $2.65 | $50.2K | 0 |
| Mar 7, 2025 | Wargacki Stephen | Chief Science Officer | Sell | 32,862 | $2.63 | $86.6K | 0 |
| Nov 26, 2024 | Jung Cassie | Chief Operating Officer | Sell | 44 | $4.87 | $214.06 | 0 |
| Aug 9, 2024 | Kraus Carl N | Chief Medical Officer | Sell | 10,819 | $3.43 | $37.1K | 0 |
| Mar 15, 2024 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sell | 50,000 | $6.00 | $300.0K | 0 |
| Mar 9, 2024 | Barber Daniel | President and CEO | Sell | 37,938 | $4.88 | $185.1K | 0 |
| Mar 9, 2024 | Boyd Peter E. | See Remark | Sell | 8,370 | $4.88 | $40.8K | 0 |
| Mar 9, 2024 | BRAENDER LORI J | SVP, General Counsel | Sell | 10,530 | $4.88 | $51.4K | 0 |
| Mar 9, 2024 | Jung Cassie | SVP, Operations | Sell | 9,432 | $4.88 | $46.0K | 0 |
| Mar 9, 2024 | TOTH A ERNEST JR | SVP, Chief Financial Officer | Sell | 11,705 | $4.88 | $57.1K | 0 |
| Mar 9, 2024 | Wargacki Stephen | SVP, Research & Development | Sell | 12,956 | $4.88 | $63.2K | 0 |
| Mar 8, 2024 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sell | 30,895 | $5.13 | $158.5K | 0 |
| Mar 10, 2023 | Wargacki Stephen | SVP, Research & Development | Sell | 1,981 | $0.79 | $1.6K | 0 |
AQST Insiders
Schobel Alexander Mark
Chief Innovation/Tech Officer
Bought $44.0KSold $458.5K
3 tradesLast: Mar 15, 2024
Similar Stocks to AQST
ELAN
Elanco Animal Health Incorporated
$26.43-1.29%
$13.39B
ETON
Eton Pharmaceuticals, Inc.
$64.03+0.16%
$1.97B
ANIP
ANI Pharmaceuticals, Inc.
$70.65-1.11%
$1.56B
PCRX
Pacira BioSciences, Inc.
$36.49+0.08%
$1.46B
AMPH
Amphastar Pharmaceuticals, Inc.
$29.25-0.31%
$1.23B
EOLS
Evolus, Inc.
$6.63-4.74%
$460.7M
EBS
Emergent BioSolutions Inc.
$5.78-0.17%
$297.7M
RMTI
Rockwell Medical, Inc.
$6.75-3.98%
$35.6M